共 50 条
AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis
被引:100
|作者:
Kaplan, David E.
[1
,11
]
Bosch, Jaime
[2
,3
]
Ripoll, Cristina
[4
]
Thiele, Maja
[5
,6
]
Fortune, Brett E.
[7
]
Simonetto, Douglas A.
[8
]
Garcia-Tsao, Guadalupe
[9
,10
]
机构:
[1] Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol & Hepatol, Philadelphia, PA USA
[2] Univ Bern, Univ Hosp Bern, Dept Visceral Surg & Med, Inselspital, Bern, Switzerland
[3] Univ Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS & CIBE, Barcelona, Spain
[4] Friedrich Schiller Univ, Jena Univ Hosp, Internal Med 4, Jena, Germany
[5] Odense Univ Hosp, Dept Gastroenterol & Hepatol, Odense, Denmark
[6] Univ Southern Denmark, Inst Clin Res, Odense, Denmark
[7] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Gastroenterol, Bronx, NY USA
[8] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[9] Yale Univ, West Haven, CT USA
[10] VA CT Healthcare Syst, West Haven, CT USA
[11] 3400 Civ Ctr Dr,PCAM 708 South, Philadelphia, PA 19104 USA
来源:
关键词:
INTRAHEPATIC PORTOSYSTEMIC SHUNT;
RETROGRADE TRANSVENOUS OBLITERATION;
NONSELECTIVE BETA-BLOCKERS;
RANDOMIZED CONTROLLED-TRIAL;
VENOUS-PRESSURE GRADIENT;
MAGNETIC-RESONANCE ELASTOGRAPHY;
GASTRIC-MUCOSAL PERFUSION;
ATEZOLIZUMAB PLUS BEVACIZUMAB;
BLEEDING ESOPHAGEAL-VARICES;
LIVER STIFFNESS MEASUREMENT;
D O I:
10.1097/HEP.0000000000000647
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
[No abstract available]
引用
收藏
页码:1180 / 1211
页数:32
相关论文